BRAF V600E Mutation Positive Clinical Trials
2 recruiting trials for BRAF V600E Mutation Positive. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGNCT05639413
A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer
The study will be conducted in patients with metastatic colorectal cancer (mCRC) harboring a BRAFV600E mutation, to collect clinical data and biological samples to be used for...
Sponsor: UNICANCEREnrolling: 40020 locations
RECRUITINGPhase 2NCT05706779
Encorafenib Plus Cetuximab in a Neoadjuvant Setting in Patients With BRAF Mutation Localised Colon or Upper Rectum...
This is a pilot trial which aims to assess the concept of anti-BRAF neoadjuvant treatment (encorafenib) in combination with cetuximab in patients with colon cancer or rT3/T4...
Sponsor: Federation Francophone de Cancerologie DigestiveEnrolling: 301 location